|
|
Volumn 176, Issue 2, 2002, Pages 88-89
|
|
COX-2 inhibition and thrombotic tendency
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
IBUPROFEN;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROFECOXIB;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COMMUNITY CARE;
DATA ANALYSIS;
DOSE RESPONSE;
DRUG CHOICE;
DRUG CLASSIFICATION;
DRUG EXPOSURE;
DRUG INFORMATION;
DRUG SAFETY;
DRUG SELECTIVITY;
DRUG SURVEILLANCE PROGRAM;
DRUG USE;
ENZYME INHIBITION;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL SYMPTOM;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
LETTER;
LONG TERM CARE;
MEDLINE;
METHODOLOGY;
POPULATION EXPOSURE;
REGISTRATION;
RISK BENEFIT ANALYSIS;
STANDARD;
STATISTICAL ANALYSIS;
THROMBOSIS;
TIME MANAGEMENT;
|
|
EID: 0037148304
PISSN: 0025729X
EISSN: None
Source Type: Journal
DOI: 10.5694/j.1326-5377.2002.tb04303.x Document Type: Letter |
|
Times cited : (2)
|
|
References (0)
|
